National Planning Corporation’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-6,717
| Closed | -$274K | – | 724 |
|
|
2016
Q3 | $274K | Sell |
6,717
-410
| -6% | -$16.7K | 0.02% | 503 |
|
|
2016
Q2 | $377K | Buy |
7,127
+150
| +2% | +$7.94K | 0.03% | 439 |
|
|
2016
Q1 | $351K | Sell |
6,977
-3,275
| -32% | -$165K | 0.03% | 440 |
|
|
2015
Q4 | $603K | Buy |
10,252
+4,025
| +65% | +$237K | 0.05% | 350 |
|
|
2015
Q3 | $383K | Hold |
6,227
| – | – | 0.04% | 400 |
|
|
2015
Q2 | $433K | Buy |
6,227
+109
| +2% | +$7.58K | 0.04% | 391 |
|
|
2015
Q1 | $376K | Sell |
6,118
-3,800
| -38% | -$234K | 0.03% | 428 |
|
|
2014
Q4 | $568K | Buy |
9,918
+253
| +3% | +$14.5K | 0.04% | 369 |
|
|
2014
Q3 | $531K | Sell |
9,665
-98
| -1% | -$5.38K | 0.04% | 383 |
|
|
2014
Q2 | $512K | Buy |
9,763
+1,812
| +23% | +$95K | 0.04% | 387 |
|
|
2014
Q1 | $424K | Buy |
7,951
+456
| +6% | +$24.3K | 0.04% | 426 |
|
|
2013
Q4 | $299K | Sell |
7,495
-395
| -5% | -$15.8K | 0.03% | 520 |
|
|
2013
Q3 | $300K | Buy |
7,890
+1,216
| +18% | +$46.2K | 0.03% | 488 |
|
|
2013
Q2 | $263K | Buy |
+6,674
| New | +$263K | 0.03% | 418 |
|